FNCH News and Press, Finch Therapeutics Group Inc. From 05/16/22

Finch Therapeutics press release (NASDAQ:FNCH): Q1 GAAP EPS of -$0.52. Revenue of $0.35M. Susan Graf appointed board chair and Howard Franklin chief medical officer. Shares +3.59%. For further details see: Finch Therapeutics GAAP EPS of -$0.52, revenue of $0.35M

FDA lifted clinical hold on IND for CP101 Enrollment in PRISM4 Phase 3 trial of CP101 in recurrent CDI expected to proceed in H2 2022 $15 million drawn from new $55 million term debt facility Anticipated cash runway into Q2 2024 Corporate update call to...

Seth Klarman’s 13F portfolio value decreased from $10.13B to $9.30B this quarter. Baupost Group increased Fiserv, Dropbox, Encompass Health, Nuvation Bio, and ironSource while reducing Joby Aviation and dropping Pershing Square Tontine and NortonLifeLock. The portfolio cont...

Gainers: Better Therapeutics (BTTX) +34%. Great Elm (GEG) +9%. Nuvectis Pharma (NVCT) +8%. Viatris (VTRS) +5%. BioNTech (BNTX) +3%. Losers: TherapeuticsMD (TXMD) -30%. Sutro Biopharma (STRO) -12%. NanoViricides (NNVC) -12%. RedHill Biopharma (RDHL)...

SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery ® platform to develop a novel c...

Gainers: GTY Technology Holdings (GTYH) +114%. Vaxxinity (VAXX) +57%. Zymeworks (ZYME) +35%. Redbox Entertainment (RDBX) +33%. Finch Therapeutics Group (FNCH) +29%. Opiant Pharmaceuticals (OPNT) +29%. Puyi (PUYI) +27%. Cyngn (CYN) +24%. Clearwater (CLW) +24%. Anixa Biosciences (ANIX) +21%. Lo...

Shares of Finch Therapeutics Group (NASDAQ: FNCH) were skyrocketing 35.7% higher as of 11:32 a.m. ET on Friday. The huge gain came after the company announced that the U.S. Food and Drug Administration (FDA) has removed a clinical hold on the investigational new drug (IND) applicati...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finch Therapeutics (NASDAQ: FNCH ) stock is rising higher on Friday following news that the U.S. Food and Drug Administration (FDA) has released its clinical hold on CP101. Source: Shutterstock CP101 is Finch ...

Gainers: Finch Therapeutics (FNCH) +46%. Zymeworks (ZYME) +44%. Lantheus (LNTH) +13%. BeiGene (BGNE) +12%. Inari Medical (NARI) +11%. Losers: Accolade (ACCD) -55%. Aldeyra Therapeutics (ALDX) -15%. Venus Concept (VERO) -14%. Bio...

What to Know About Buying Penny Stocks Today With so much going on in the stock market right now, there is a lot for investors to know about trading penny stocks. To understand how to make money with penny stocks , investors need to have a thorough consideration of what is going on ...